| 2024-05-20 | Sale | Stoke Therapeutics, Inc. STOK | CEO | 42,350 0.0779% | $15.43 | $653,529 | -7.01% | |
| 2024-03-19 | Sale | Stoke Therapeutics, Inc. STOK | CEO | 11,150 0.0263% | $6.10 | $67,999 | +125.3% | |
| 2022-08-05 | Sale | Cytokinetics, Incorporated CYTK | 11,428 0.0118% | $50.00 | $571,400 | -22.6% | ||
| 2021-12-23 | Sale | Cytokinetics, Incorporated CYTK | director | 15,000 0.018% | $45.00 | $675,000 | -9.39% | |
| 2020-12-18 | Sale | Stoke Therapeutics, Inc. STOK | CEO | 5,194 0.0155% | $60.00 | $311,640 | -45.5% | |
| 2020-12-17 | Sale | Stoke Therapeutics, Inc. STOK | CEO | 19,806 0.0596% | $60.00 | $1.19M | -44.87% | |
| 2020-11-27 | Sale | Stoke Therapeutics, Inc. STOK | CEO | 12,152 0.0357% | $50.00 | $607,600 | -33.4% | |
| 2020-11-25 | Sale | Stoke Therapeutics, Inc. STOK | CEO | 12,848 0.0402% | $50.00 | $642,400 | -28.61% | |
| 2020-10-05 | Sale | Cytokinetics, Incorporated CYTK | director | 20,000 0.0325% | $30.00 | $600,000 | -22.61% | |
| 2017-07-20 | Sale | Sarepta Therapeutics, Inc. SRPT | director | 10,000 0.0163% | $41.00 | $410,000 | +46.25% | |
| 2016-09-22 | Sale | Sarepta Therapeutics, Inc. SRPT | President, CEO & CMO | 40,179 0.0819% | $60.00 | $2.41M | -43.78% | |
| 2016-09-19 | Sale | Sarepta Therapeutics, Inc. SRPT | President, CEO & CMO | 10,405 0.022% | $50.00 | $520,250 | -29.97% | |
| 2016-09-14 | Sale | Sarepta Therapeutics, Inc. SRPT | SVP Interim CEO & CMO | 24,557 0.047% | $30.00 | $736,710 | +5.42% | |
| 2015-02-27 | Sarepta Therapeutics, Inc. SRPT | SVP & Chief Medical Officer | 800 0.0016% | $11.81 | $9,452 | +102.3% |